ZA943610B - Oligopeptides derived from c-reactive protein fragments - Google Patents

Oligopeptides derived from c-reactive protein fragments

Info

Publication number
ZA943610B
ZA943610B ZA943610A ZA943610A ZA943610B ZA 943610 B ZA943610 B ZA 943610B ZA 943610 A ZA943610 A ZA 943610A ZA 943610 A ZA943610 A ZA 943610A ZA 943610 B ZA943610 B ZA 943610B
Authority
ZA
South Africa
Prior art keywords
pct
reactive protein
protein fragments
oligopeptides derived
derived
Prior art date
Application number
ZA943610A
Other languages
English (en)
Inventor
Patrizia Caretto
Fabrizio Marcucci
Paolo Mascagni
Silvana Cappelletti
Flavio Leoni
Gianni Gromo
Massimo Pinori
Original Assignee
Italfamaco S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italfamaco S P A filed Critical Italfamaco S P A
Publication of ZA943610B publication Critical patent/ZA943610B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4737—C-reactive protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA943610A 1993-10-12 1994-05-24 Oligopeptides derived from c-reactive protein fragments ZA943610B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI932154A IT1271486B (it) 1993-10-12 1993-10-12 Oligopeptidi immunomodulatori derivati di frammenti della proteina c- reattiva

Publications (1)

Publication Number Publication Date
ZA943610B true ZA943610B (en) 1995-01-25

Family

ID=11367010

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA943610A ZA943610B (en) 1993-10-12 1994-05-24 Oligopeptides derived from c-reactive protein fragments

Country Status (19)

Country Link
US (1) US6057295A (fr)
EP (1) EP0723552B1 (fr)
JP (1) JP3221881B2 (fr)
KR (1) KR100363408B1 (fr)
CN (1) CN1041524C (fr)
AT (1) ATE226591T1 (fr)
AU (1) AU684511B2 (fr)
CA (1) CA2173939C (fr)
DE (1) DE69431603T2 (fr)
DK (1) DK0723552T3 (fr)
ES (1) ES2185652T3 (fr)
FI (1) FI961584A0 (fr)
HU (1) HUT75538A (fr)
IL (1) IL109761A0 (fr)
IT (1) IT1271486B (fr)
NO (1) NO961423L (fr)
PT (1) PT723552E (fr)
WO (1) WO1995010531A1 (fr)
ZA (1) ZA943610B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6342481B1 (en) * 1993-10-12 2002-01-29 Italfarmaco S.P.A. Oligopeptides derived from C-reactive protein fragments
EP1408031A1 (fr) * 2002-10-09 2004-04-14 3 D Gene Pharma Derivés de pyrolidine comme médicaments contre Hepatitis C
EP2341942A1 (fr) 2008-09-19 2011-07-13 Nektar Therapeutics Conjugués polymères de peptides thérapeutiques
CN102947341B (zh) 2010-01-19 2018-07-06 哈佛大学校长及研究员协会 用于病原体检测和治疗的工程化调理素
WO2013012924A2 (fr) 2011-07-18 2013-01-24 President And Fellows Of Harvard College Molécules manipulées ciblant un microbe et leurs utilisations
EP2976642A4 (fr) 2013-03-15 2016-09-21 Harvard College Procédés et compositions pour améliorer la détection et/ou la capture d'une entité cible
WO2014190040A1 (fr) 2013-05-21 2014-11-27 President And Fellows Of Harvard College Compositions se liant à l'hème manipulées et leurs utilisations
EP3083658B1 (fr) 2013-12-18 2019-05-08 President and Fellows of Harvard College Détection de bacteries gram positif à l'aide de crp
US10435457B2 (en) 2015-08-06 2019-10-08 President And Fellows Of Harvard College Microbe-binding molecules and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2945239A1 (de) * 1979-11-09 1981-05-21 Troponwerke GmbH & Co KG, 5000 Köln Oligopeptide, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
US4353823A (en) * 1981-09-01 1982-10-12 Chipens Gunar I Synthetic analog of tuftisin
GB8525615D0 (en) * 1985-10-17 1985-11-20 Hoffmann La Roche Polypeptides
ES2052517T3 (es) * 1986-07-16 1994-07-16 Eniricerche Spa Analogos de tuftsina parcialmente retroinversos, metodo de preparacion de los mismos y composiciones farmaceuticas que los contienen.
IT1254883B (it) * 1992-04-16 1995-10-11 Italfarmaco Spa Tetrapeptidi parzialmente modificati e retroinvertiti, analoghi di frammenti della proteina c-reattiva.

Also Published As

Publication number Publication date
ITMI932154A1 (it) 1995-04-12
PT723552E (pt) 2003-02-28
CN1041524C (zh) 1999-01-06
JPH09503200A (ja) 1997-03-31
HU9600934D0 (en) 1996-08-28
NO961423D0 (no) 1996-04-11
FI961584A7 (fi) 1996-04-11
EP0723552B1 (fr) 2002-10-23
FI961584L (fi) 1996-04-11
AU684511B2 (en) 1997-12-18
IL109761A0 (en) 1994-08-26
ATE226591T1 (de) 2002-11-15
FI961584A0 (fi) 1996-04-11
IT1271486B (it) 1997-05-28
NO961423L (no) 1996-06-10
HUT75538A (en) 1997-05-28
ITMI932154A0 (it) 1993-10-12
EP0723552A1 (fr) 1996-07-31
CN1133048A (zh) 1996-10-09
DE69431603T2 (de) 2003-03-13
AU6844194A (en) 1995-05-04
WO1995010531A1 (fr) 1995-04-20
KR100363408B1 (ko) 2003-02-11
ES2185652T3 (es) 2003-05-01
DE69431603D1 (de) 2002-11-28
US6057295A (en) 2000-05-02
CA2173939A1 (fr) 1995-04-20
JP3221881B2 (ja) 2001-10-22
DK0723552T3 (da) 2003-02-24
CA2173939C (fr) 2002-08-27

Similar Documents

Publication Publication Date Title
WO1998033509A3 (fr) Proprietes utiles de la lactoferrine humaine et de variants de celle-ci
WO1998026747A3 (fr) Procedes et compositions de traitement de maladies a base de superantigenes
GR3035440T3 (en) Therapeutic uses of bpi protein products for human meningococcemia
EP1642506A3 (fr) Utilisation de subtilisines stables en milieu acide dans des aliments pour animaux
DE69727142D1 (de) Verwendung eines bpi proteinproduktes als antithrombotisches mittel
GB2288732B (en) Pharmaceutical compositions
WO1996017935A3 (fr) Peptide rantes et fragments et compositions comprenant ce peptide, pour le traitement de l'inflammation
NZ332954A (en) Use of BPI protein products to treat humans with hemorrhage due to trauma
AU3477295A (en) Modified proteins
HU9600934D0 (en) Oligopeptides derived from c-reactive protein fragments
AU1384995A (en) Human circulating cytokine cc-1
WO2001007479A3 (fr) Matieres vivantes et methodes utiles pour le diagnostic ou le traitement de maladies
CA2136841A1 (fr) Nouveaux piperidylamides, sulfonamides et sulfoxamides utilisees comme inhibiteurs de la biosynthese du cholesterol
ATE316136T1 (de) Nierenpolycystose-gen
GB2374871A (en) Peptide fragments of colostrinin and their use
HU9600727D0 (en) Triaryl-ethylene derivatives for use in therapy
NZ228208A (en) Eglin compounds (hurudin) and protease inhibitor pharmaceutical compositions
EP1671646A3 (fr) Procédés de traitement de troubles associés à IgE et compositions pouvant être utilisées à cet effet.
HUP0000812A3 (en) Peptide fragments of myelin basic protein, their pharmaceutical compositions and their use in treating multiple sclerosis
BG102937A (en) Zona pelucida proteins as contraceptives
GB9723824D0 (en) Cytostatic agents
LT2001045A (en) Compositions and use thereof for downmodulating the immune response to therapeutic proteins
AU1507300A (en) Pharmaceutical compositions containing proteins
IL106081A0 (en) Pharmaceutical agents combining antiinflammatory,free radical inhibitor and protein modification inhibitor properties
AU5382598A (en) N-terminally modified polypeptide enzyme inhibitors, and related therapeutic methods and pharmaceutical compositions